Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Edward Havranek to Middle Aged

This is a "connection" page, showing publications Edward Havranek has written about Middle Aged.

 
Connection Strength
  
 
 
0.780
  
  1. Daugherty SL, Helmkamp L, Vupputuri S, Hanratty R, Steiner JF, Blair IV, Dickinson LM, Maertens JA, Havranek EP. Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial. JAMA Netw Open. 2021 12 01; 4(12):e2139533.
    View in: PubMed
    Score: 0.049
  2. Ritchie ND, Carroll JK, Holtrop JS, Havranek EP. Effects of physical activity goal attainment on engagement and outcomes in the National Diabetes Prevention Program. Transl Behav Med. 2018 11 21; 8(6):932-937.
    View in: PubMed
    Score: 0.040
  3. Havranek EP. Epidemiology of heart disease: The influence of socioeconomic position. Trends Cardiovasc Med. 2019 07; 29(5):298-303.
    View in: PubMed
    Score: 0.039
  4. Beck A, Davidson AJ, Xu S, Josh Durfee M, Oronce CIA, Steiner JF, Havranek E. A Multilevel Analysis of Individual, Health System, and Neighborhood Factors Associated with Depression within a Large Metropolitan Area. J Urban Health. 2017 Dec; 94(6):780-790.
    View in: PubMed
    Score: 0.037
  5. Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Moore SL, Durfee MJ, Raghunath SG, Tsai AG, Havranek EP. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care. 2016 Aug; 39(8):1364-70.
    View in: PubMed
    Score: 0.033
  6. Blair IV, Steiner JF, Hanratty R, Price DW, Fairclough DL, Daugherty SL, Bronsert M, Magid DJ, Havranek EP. An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control. J Gen Intern Med. 2014 Jul; 29(7):987-95.
    View in: PubMed
    Score: 0.028
  7. Blair IV, Steiner JF, Fairclough DL, Hanratty R, Price DW, Hirsh HK, Wright LA, Bronsert M, Karimkhani E, Magid DJ, Havranek EP. Clinicians' implicit ethnic/racial bias and perceptions of care among Black and Latino patients. Ann Fam Med. 2013 Jan-Feb; 11(1):43-52.
    View in: PubMed
    Score: 0.026
  8. Havranek EP, Hanratty R, Tate C, Dickinson LM, Steiner JF, Cohen G, Blair IA. The effect of values affirmation on race-discordant patient-provider communication. Arch Intern Med. 2012 Nov 26; 172(21):1662-7.
    View in: PubMed
    Score: 0.026
  9. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9.
    View in: PubMed
    Score: 0.024
  10. Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP. Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertension. BMC Cardiovasc Disord. 2011 Apr 11; 11:15.
    View in: PubMed
    Score: 0.023
  11. Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, Plomondon ME, Havranek EP. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011 Apr; 17(4):e96-103.
    View in: PubMed
    Score: 0.023
  12. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010 Mar; 3(2):181-7.
    View in: PubMed
    Score: 0.022
  13. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant. 2010 Mar; 25(3):801-7.
    View in: PubMed
    Score: 0.021
  14. Havranek EP, Allen LA. Listening to patients. J Am Coll Cardiol. 2008 Nov 18; 52(21):1709-10.
    View in: PubMed
    Score: 0.020
  15. Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, Dickinson LM, Steiner JF. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008 Oct; 121(10):870-5.
    View in: PubMed
    Score: 0.020
  16. Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO, Dickinson LM, Steiner JF. Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol. 2008 Jul-Aug; 41(4):342-50.
    View in: PubMed
    Score: 0.019
  17. Riegel B, Moser DK, Powell M, Rector TS, Havranek EP. Nonpharmacologic care by heart failure experts. J Card Fail. 2006 Mar; 12(2):149-153.
    View in: PubMed
    Score: 0.016
  18. Havranek EP, Spertus JA, Masoudi FA, Jones PG, Rumsfeld JS. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol. 2004 Dec 21; 44(12):2333-8.
    View in: PubMed
    Score: 0.015
  19. Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P. The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail. 2004 Aug; 10(4):339-43.
    View in: PubMed
    Score: 0.015
  20. Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. Am Heart J. 2003 Jun; 145(6):993-8.
    View in: PubMed
    Score: 0.014
  21. Henderson KH, Helmkamp LJ, Steiner JF, Havranek EP, Vupputuri SX, Hanratty R, Blair IV, Maertens JA, Dickinson M, Daugherty SL. Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial. Circ Cardiovasc Qual Outcomes. 2022 05; 15(5):e007709.
    View in: PubMed
    Score: 0.013
  22. Trent SA, George N, Havranek EP, Ginde AA, Haukoos JS. Established evidence-based treatment guidelines help mitigate disparities in quality of emergency care. Acad Emerg Med. 2021 09; 28(9):1051-1060.
    View in: PubMed
    Score: 0.012
  23. Perman SM, Beaty BL, Daugherty SL, Havranek EP, Haukoos JS, Juarez-Colunga E, Bradley SM, Fendler TJ, Chan PS. Do Sex Differences Exist in the Establishment of "Do Not Attempt Resuscitation" Orders and Survival in Patients Successfully Resuscitated From In-Hospital Cardiac Arrest? J Am Heart Assoc. 2020 02 18; 9(4):e014200.
    View in: PubMed
    Score: 0.011
  24. Mansoori JN, Linde-Zwirble W, Hou PC, Havranek EP, Douglas IS. Variability in usual care fluid resuscitation and risk-adjusted outcomes for mechanically ventilated patients in shock. Crit Care. 2020 01 28; 24(1):25.
    View in: PubMed
    Score: 0.011
  25. Perman SM, Shelton SK, Knoepke C, Rappaport K, Matlock DD, Adelgais K, Havranek EP, Daugherty SL. Public Perceptions on Why Women Receive Less Bystander Cardiopulmonary Resuscitation Than Men in Out-of-Hospital Cardiac Arrest. Circulation. 2019 02 19; 139(8):1060-1068.
    View in: PubMed
    Score: 0.010
  26. Cervantes L, Chonchol M, Hasnain-Wynia R, Steiner JF, Havranek E, Hull M, Rice J, Kendrick J, Alamillo X, Camacho C, Fischer S. Peer Navigator Intervention for Latinos on Hemodialysis: A Single-Arm Clinical Trial. J Palliat Med. 2019 07; 22(7):838-843.
    View in: PubMed
    Score: 0.010
  27. Trent SA, Jarou ZJ, Havranek EP, Ginde AA, Haukoos JS. Variation in Emergency Department Adherence to Treatment Guidelines for Inpatient Pneumonia and Sepsis: A Retrospective Cohort Study. Acad Emerg Med. 2019 08; 26(8):908-920.
    View in: PubMed
    Score: 0.010
  28. Trent SA, Morse EA, Ginde AA, Havranek EP, Haukoos JS. Barriers to Prompt Presentation to Emergency Departments in Colorado after Onset of Stroke Symptoms. West J Emerg Med. 2019 Mar; 20(2):237-243.
    View in: PubMed
    Score: 0.010
  29. Trent SA, Havranek EP, Ginde AA, Haukoos JS. Effect of Audit and Feedback on Physician Adherence to Clinical Practice Guidelines for Pneumonia and Sepsis. Am J Med Qual. 2019 May/Jun; 34(3):217-225.
    View in: PubMed
    Score: 0.010
  30. Bekelman DB, Allen LA, McBryde CF, Hattler B, Fairclough DL, Havranek EP, Turvey C, Meek PM. Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):511-519.
    View in: PubMed
    Score: 0.009
  31. Trent SA, Johnson MA, Morse EA, Havranek EP, Haukoos JS. Patient, provider, and environmental factors associated with adherence to cardiovascular and cerebrovascular clinical practice guidelines in the ED. Am J Emerg Med. 2018 08; 36(8):1397-1404.
    View in: PubMed
    Score: 0.009
  32. Ritchie ND, Christoe-Frazier L, McFann KK, Havranek EP, Pereira RI. Effect of the National Diabetes Prevention Program on Weight Loss for English- and Spanish-Speaking Latinos. Am J Health Promot. 2018 03; 32(3):812-815.
    View in: PubMed
    Score: 0.009
  33. Pflederer MC, Long CS, Beaty B, Havranek EP, Mehler PS, Keniston A, Krantz MJ. Longitudinal Changes in Vascular Risk Markers and Mortality Rates among a Latino Population with Hypertension. Tex Heart Inst J. 2016 Apr; 43(2):131-6.
    View in: PubMed
    Score: 0.008
  34. Pereira RI, Low Wang CC, Wolfe P, Havranek EP, Long CS, Bessesen DH. Associations of Adiponectin with Adiposity, Insulin Sensitivity, and Diet in Young, Healthy, Mexican Americans and Non-Latino White Adults. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010054.
    View in: PubMed
    Score: 0.008
  35. Krantz MJ, Havranek EP, Pereira RI, Beaty B, Mehler PS, Long CS. Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study. J Negat Results Biomed. 2015 Dec 02; 14:21.
    View in: PubMed
    Score: 0.008
  36. Martin SS, Faridi KF, Joshi PH, Blaha MJ, Kulkarni KR, Khokhar AA, Maddox TM, Havranek EP, Toth PP, Tang F, Spertus JA, Jones SR. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry. Clin Cardiol. 2015 Nov; 38(11):660-7.
    View in: PubMed
    Score: 0.008
  37. Blair IV, Havranek EP, Price DW, Hanratty R, Fairclough DL, Farley T, Hirsh HK, Steiner JF. Assessment of biases against Latinos and African Americans among primary care providers and community members. Am J Public Health. 2013 Jan; 103(1):92-8.
    View in: PubMed
    Score: 0.007
  38. Schroeder EB, Hanratty R, Beaty BL, Bayliss EA, Havranek EP, Steiner JF. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53.
    View in: PubMed
    Score: 0.006
  39. Peterson PN, Campagna EJ, Maravi M, Allen LA, Bull S, Steiner JF, Havranek EP, Dickinson LM, Masoudi FA. Acculturation and outcomes among patients with heart failure. Circ Heart Fail. 2012 Mar 01; 5(2):160-6.
    View in: PubMed
    Score: 0.006
  40. Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2605-11.
    View in: PubMed
    Score: 0.006
  41. Padilla R, Steiner JF, Havranek EP, Beaty B, Davidson AJ, Bull S. A comparison of different measures of acculturation with cardiovascular risk factors in Latinos with hypertension. J Immigr Minor Health. 2011 Apr; 13(2):284-92.
    View in: PubMed
    Score: 0.006
  42. Lambert-Kerzner A, Havranek EP, Plomondon ME, Albright K, Moore A, Gryniewicz K, Magid D, Ho PM. Patients' perspectives of a multifaceted intervention with a focus on technology: a qualitative analysis. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):668-74.
    View in: PubMed
    Score: 0.006
  43. Lipska KJ, Wang Y, Kosiborod M, Masoudi FA, Havranek EP, Krumholz HM, Inzucchi SE. Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):236-42.
    View in: PubMed
    Score: 0.005
  44. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):451-7.
    View in: PubMed
    Score: 0.005
  45. Bekelman DB, Rumsfeld JS, Havranek EP, Yamashita TE, Hutt E, Gottlieb SH, Dy SM, Kutner JS. Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med. 2009 May; 24(5):592-8.
    View in: PubMed
    Score: 0.005
  46. Cleary BS, Keniston A, Havranek EP, Albert RK. Intimate partner violence in women hospitalized on an internal medicine service: prevalence and relationship to responses to the review of systems. J Hosp Med. 2008 Jul; 3(4):299-307.
    View in: PubMed
    Score: 0.005
  47. Hanratty R, Estacio RO, Dickinson LM, Chandramouli V, Steiner JF, Havranek EP. Testing electronic algorithms to create disease registries in a safety net system. J Health Care Poor Underserved. 2008 May; 19(2):452-65.
    View in: PubMed
    Score: 0.005
  48. Krantz MJ, Havranek EP, Haynes DK, Smith I, Bucher-Bartelson B, Long CS. Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study. J Card Fail. 2008 May; 14(4):303-9.
    View in: PubMed
    Score: 0.005
  49. Ho PM, Eng MH, Rumsfeld JS, Spertus JA, Peterson PN, Jones PG, Peterson ED, Alexander KP, Havranek EP, Krumholz HM, Masoudi FA. The influence of age on health status outcomes after acute myocardial infarction. Am Heart J. 2008 May; 155(5):855-61.
    View in: PubMed
    Score: 0.005
  50. Plomondon ME, Magid DJ, Masoudi FA, Jones PG, Barry LC, Havranek E, Peterson ED, Krumholz HM, Spertus JA, Rumsfeld JS. Association between angina and treatment satisfaction after myocardial infarction. J Gen Intern Med. 2008 Jan; 23(1):1-6.
    View in: PubMed
    Score: 0.005
  51. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6.
    View in: PubMed
    Score: 0.005
  52. Conard MW, Haddock CK, Poston WS, Havranek E, McCullough P, Spertus J. Impact of obesity on the health status of heart failure patients. J Card Fail. 2006 Dec; 12(9):700-6.
    View in: PubMed
    Score: 0.004
  53. Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN, Krumholz HM, Spertus JA, Rumsfeld JS. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006 Feb; 12(1):54-60.
    View in: PubMed
    Score: 0.004
  54. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006 Feb 21; 47(4):752-6.
    View in: PubMed
    Score: 0.004
  55. Luther SA, McCullough PA, Havranek EP, Rumsfeld JS, Jones PG, Heidenreich PA, Peterson ED, Rathore SS, Krumholz HM, Weintraub WS, Spertus JA, Masoudi FA. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005 Aug; 11(6):414-21.
    View in: PubMed
    Score: 0.004
  56. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA. Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004 Oct; 10(5):368-73.
    View in: PubMed
    Score: 0.004
  57. Krantz MJ, Havranek EP, Mehler PS, Haynes DK, Long CS. Impact of a cardiac risk reduction program in vulnerable patients hospitalized with coronary artery disease. Pharmacotherapy. 2004 Jun; 24(6):768-75.
    View in: PubMed
    Score: 0.004
  58. Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW. Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. J Card Fail. 2004 Apr; 10(2):126-31.
    View in: PubMed
    Score: 0.004
  59. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003 Nov 19; 42(10):1811-7.
    View in: PubMed
    Score: 0.003
  60. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 Mar 19; 105(11):1348-53.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)